Jazz Pharmaceuticals
JAZZ
₹9,133
Share price
-0.57%
Change (1 day)
2.63%
Change (1 year)
Categories
Jazz Pharmaceuticals (JAZZ) - Total debt
Total debt on the balance sheet as of March 2025 : ₹463.01 Billion
According to Jazz Pharmaceuticals's latest financial reports the company's total debt is ₹463.01 Billion. A company’s total debt is the sum of all current and non-current debts.
Jazz Pharmaceuticals - Total debt on balance sheet (from 2005 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | ₹528.64 B | 9.64% |
| 2023-12-31 | ₹482.14 B | 0.25% |
| 2022-12-31 | ₹480.95 B | 5.02% |
| 2021-12-31 | ₹457.96 B | 178.4% |
| 2020-12-31 | ₹164.50 B | 30.24% |
| 2019-12-31 | ₹126.30 B | 13.15% |
| 2018-12-31 | ₹111.62 B | 10.57% |
| 2017-12-31 | ₹100.95 B | -26.81% |
| 2016-12-31 | ₹137.92 B | 74.63% |
| 2015-12-31 | ₹78.97 B | -7.17% |
| 2014-12-31 | ₹85.08 B | 150.4% |
| 2013-12-31 | ₹33.97 B | 35.86% |
| 2012-12-31 | ₹25.00 B | |
| 2010-12-31 | ₹2.15 B | -62.66% |
| 2009-12-31 | ₹5.76 B | -2% |
| 2008-12-31 | ₹5.88 B | 90.8% |
| 2007-12-31 | ₹3.08 B | -8.96% |
| 2006-12-31 | ₹3.38 B | 2.23% |
| 2005-12-31 | ₹3.31 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Endo International
ENDPQ | ₹0.43 B | -99.91% | 🇮🇪 Ireland |
 AmerisourceBergen
ABC | ₹428.92 B | -7.36% | 🇺🇸 USA |
 Novartis NVS | ₹2.671 T | 476.97% | 🇨🇭 Switzerland |
 Teva Pharmaceutical Industries TEVA | ₹1.447 T | 212.54% | 🇮🇱 Israel |